| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.1M | — | — |
| Cost of Revenue | $23.3M | — | — |
| Gross Profit | $7.8M | — | — |
| R&D Expense | $2.0M | — | — |
| SG&A Expense | $8.9M | — | — |
| Operating Income | -$3.1M | — | — |
| Interest Expense | $6.4M | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.9M | — | — |
| Inventory | $33.8M | — | — |
| Current Assets | $83.9M | — | — |
| Total Assets | $235.2M | — | — |
| Current Liabilities | $30.0M | — | — |
| Long-term Debt | $136.0M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.8M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | -$1.7M | — | — |
| Financing Cash Flow | -$1.4M | — | — |
| Free Cash Flow | $25K | — | — |
| Pre-tax Income | -$9.7M | — | — |
| Income Tax | $333K | — | — |
| Net Income | -$10.0M | — | — |
| EPS (Basic) | -$0.29 | — | — |
| EPS (Diluted) | -$0.29 | — | — |
| — |
| Total Liabilities | $198.4M | — | — |
| Stockholders' Equity | -$10.5M | -1123.8% | — |